Estimating economic efficiency of preclinical diagnostics of Parkinson's disease with cost-utility approach

Irina A. Denisova; Tatiana V. Chubarova; Irina E. Bogatova; Sergei A. Vartanov; Valerian G. Kucheryanu; Viсtor M. Polterovich; Natalia A. Turdyeva; Marina V. Shakleina

doi:10.3897/popecon.4.e59949

Research Article

Population and Economics 4(3): 111-127
https://doi.org/10.3897/popecon.4.e59949 (29 Dec 2020)

Other versions:

(1)

A. W. Willis, E. Roberts, J. C. Beck, B. Fiske, W. Ross, R. Savica, S. K. Van Den Eeden, C. M. Tanner, C. Marras, Roy Alcalay, Michael Schwarzschild, Brad Racette, Honglei Chen, Tim Church, Bill Wilson, James M. Doria (2022)
Incidence of Parkinson disease in North America. npj Parkinson's Disease 8: .

DOI: 10.1038/s41531-022-00410-y

Subscribe to email alerts for current Article's categories

This website uses cookies in order to improve your web experience. Read our Cookies Policy